Nuvectis Pharma Inc Share Price Today: Live Updates & Key Insights

Nuvectis Pharma Inc share price today is $8.2, up 1.86%. The stock opened at $7.93 against the previous close of $8.08, with an intraday high of $8.26 and low of $7.93.

Nuvectis Pharma Inc Share Price Chart

Nuvectis Pharma Inc

us-stock
To Invest in {{usstockname}}
us-stock

Nuvectis Pharma Inc Share Price Performance

$8.2 0.0186(1.86%) NVCT at 23 Mar 2026 02:32 PM Biotechnology
Lowest Today 7.93
Highest Today 8.26
Today’s Open 7.93
Prev. Close 8.08
52 Week High 11.52
52 Week Low 5.55
Day’s Range: Low 7.93 High 8.26
52-Week Range: Low 5.55 High 11.52
1 day return -
1 Week return -8.13
1 month return -3.62
3 month return -0.66
6 month return +28.54
1 year return -14.34
3 year return -32.18
5 year return -
10 year return -

Nuvectis Pharma Inc Institutional Holdings

Vanguard Group Inc 3.19

BlackRock Inc 2.59

Iridian Asset Management LLC 2.21

Vanguard Total Stock Mkt Idx Inv 1.66

Baldwin Brothers Inc 1.47

Occam Crest Management L.P. 1.43

iShares Russell 2000 ETF 1.33

Geode Capital Management, LLC 1.23

Vanguard Institutional Extnd Mkt Idx Tr 0.65

Fidelity Small Cap Index 0.57

State Street Corp 0.52

iShares Russell 2000 Growth ETF 0.48

Northern Trust Corp 0.40

Susquehanna International Group, LLP 0.34

Fidelity Extended Market Index 0.34

Vanguard Russell 2000 ETF 0.28

Oppenheimer & Co Inc 0.28

Forbes J M & Co 0.22

The Goldman Sachs Group Inc 0.17

State St Russell Sm Cap® Indx SL Cl I 0.17

Charles Schwab Investment Management Inc 0.17

iShares Micro-Cap ETF 0.16

Schwab Small Cap Index 0.15

NT R2000 Index Fund - NL 0.13

Royal Bank of Canada 0.12

Blackrock Extended Mkt Fund CF 0.11

Bank of New York Mellon Corp 0.11

Fidelity Total Market Index 0.11

NT R2000 Index Fund - DC - NL - 3 0.10

Jane Street Group LLC 0.10

Extended Equity Market Fund K 0.10

UBS Group AG 0.10

Spartan Extended Market Index Pool F 0.09

iShares Russell 2000 Small-Cap Idx Instl 0.08

Fidelity Series Total Market Index 0.08

Austin Wealth Management LLC 0.08

NT Ext Equity Mkt Idx Fd - L 0.08

Russell 2500™ Index Fund F 0.07

Morgan Stanley - Brokerage Accounts 0.07

Barclays PLC 0.07

Nuvectis Pharma Inc Market Status

Strong Buy: 2

Buy: 4

Hold: 0

Sell: 0

Strong Sell: 0

Nuvectis Pharma Inc Fundamentals

Market Cap 218.03 M

PB Ratio 11.8193

PE Ratio 0.0

Enterprise Value 186.00 M

Total Assets 31.71 M

Volume 113027

Nuvectis Pharma Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:149000 0.1M, FY21:0 0.0M

Annual Profit FY25:null 0.0M, FY24:null 0.0M, FY23:null 0.0M, FY22:-19085000 -19.1M, FY21:-12894000 -12.9M

Annual Net worth FY25:-26442000 -26.4M, FY24:-19000000 -19.0M, FY23:-22334000 -22.3M, FY22:-18787000 -18.8M, FY21:-12886000 -12.9M

Quarterly Revenue Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q4/2025:null 0.0M, Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:-4359000 -4.4M

Quarterly Net worth Q4/2025:-7314000 -7.3M, Q3/2025:-7462000 -7.5M, Q2/2025:-6334000 -6.3M, Q1/2025:-5332000 -5.3M, Q3/2024:-4153000 -4.2M

About Nuvectis Pharma Inc & investment objective

Company Information Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

Organisation Biotechnology

Employees 13

Industry Biotechnology

CEO Mr. Ron Bentsur M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Nuvectis Pharma Inc FAQs

What is the share price of Nuvectis Pharma Inc today?

The current share price of Nuvectis Pharma Inc is $8.2.

Can I buy Nuvectis Pharma Inc shares in India?

Yes, Indian investors can buy Nuvectis Pharma Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Nuvectis Pharma Inc shares in India?

You can easily invest in Nuvectis Pharma Inc shares from India by:

Can I buy fractional shares of Nuvectis Pharma Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Nuvectis Pharma Inc?

Nuvectis Pharma Inc has a market cap of $218.03 M.

In which sector does Nuvectis Pharma Inc belong?

Nuvectis Pharma Inc operates in the Biotechnology sector.

What documents are required to invest in Nuvectis Pharma Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Nuvectis Pharma Inc?

The PE ratio of Nuvectis Pharma Inc is N/A and the PB ratio is 11.82.